Kurt Putnik

Summary

Affiliation: University of Regensburg
Country: Germany

Publications

  1. ncbi Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis
    Peter Stadler
    Department of Radiotherapy and Radiation Oncology, University Hospital Regensburg, Germany
    BMC Cancer 6:279. 2006
  2. ncbi Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature
    Kurt Putnik
    Department of Radiation Oncology, University of Regensburg, Josef Strauss Allee 11, 93053 Regensburg, Germany
    Radiat Oncol 1:32. 2006

Collaborators

Detail Information

Publications2

  1. ncbi Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis
    Peter Stadler
    Department of Radiotherapy and Radiation Oncology, University Hospital Regensburg, Germany
    BMC Cancer 6:279. 2006
    ..We retrospectively analyzed the efficiency and toxicity of the Regensburg standard therapy protocol "SCHARC" and the overall survival of our patients...
  2. ncbi Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature
    Kurt Putnik
    Department of Radiation Oncology, University of Regensburg, Josef Strauss Allee 11, 93053 Regensburg, Germany
    Radiat Oncol 1:32. 2006
    ..Moreover, some phototoxic drugs seem to enhance side effects of radiotherapy while others do not. We report a case of "radiation recall dermatitis" (RRD) one year after RT as a result of taking hypericin (St. John's wort)...